Eli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its ...

CMS wants to build a standardized payment structure for clinical software and AI that factors in their impact on patient ...

Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory ...

A brain-computer interface helped restore movement and sensation in a 48-year old man with quadriplegia, researchers say.

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...

Erica Schwartz and Sean Kaufman navigated tough questions about vaccines, political independence, and pushing back on RFK Jr.

Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of ...

A trio of bipartisan lawmakers reintroduced a bill requiring the FTC and Treasury to investigate whether the U.S. relies too ...

Glenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens ...

An Alzheimer’s drug from Biogen slowed cognitive decline in a mid-stage trial at roughly comparable rates as approved ...

Sean Kaufman, Trump's pick for a key pandemic preparedness role, has questioned vaccines and criticized the CDC.

A new study claims to have uncovered how Epstein-Barr virus launches immune responses seen in people with multiple sclerosis.